This is a routine insider sale tied to option exercises and RSU vesting, not a strategic exit. The dollar amount is modest relative to market cap. Monitor for actual Form 4 filings to confirm execution. No immediate trading catalyst.
Price Chart
Executive Summary
Donald Bergstrom, an officer of Relay Therapeutics, filed a Form 144 notice of intent to sell up to 110,646 shares of common stock, with an estimated aggregate market value of approximately $1,757,058. The shares to be sold were acquired upon the exercise of stock options and the vesting of restricted stock units, indicating a routine insider sale for diversification or tax purposes rather than a distress signal.
Key Facts
- Insider: Donald Bergstrom (Officer) filed Form 144 on June 22, 2026.
- Proposed sale: up to 110,646 shares of common stock.
- Estimated aggregate market value: ~$1,757,058 (based on ~$15.88/share).
- Shares to be sold were acquired via exercise of stock options and vesting of restricted stock units (RSUs) from 12/26/2021 to 07/27/2023.
- Sale intended to be executed through Morgan Stanley Smith Barney LLC.
- Form 144 is an advance notice of intent to sell; the sale may not occur.
Financial Impact
Proposed sale of ~$1.76M in common stock, representing a small fraction of the officer's likely total holdings and less than 0.1% of the company's $3.0B market cap.
Risk Factors
- Insider may still execute the sale, creating modest selling pressure.
- If the insider sells a large portion of their remaining holdings, it could signal reduced conviction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-006399 |
| Document: 0001950047-26-006399-index.html | 0001950047-26-006399 |
| Document: 0001950047-26-006399.txt | 0001950047-26-006399 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | Insider Cluster | $18.66 $18.84 | ▲ +0.96% | ▲ +1.62% | $18.96 (+1.61%) |
Aug 28, 2026 5w ago | Insider Cluster | $18.77 $19.04 | ▼ −1.44% | ▼ −1.33% | $18.96 (−1.01%) |
Aug 18, 2026 6w ago | Insider Cluster | $20.61 $20.57 | ▲ +0.19% | ▼ −0.01% | $18.96 (+8.01%) |
Jul 8, 2026 12w ago | Insider Cluster | $19.63 $19.08 | ▼ −2.80% | ▼ −3.66% | $18.96 (−3.41%) |
Jun 22, 2026 14w ago | 144 | $17.44 $19.74 | ▲ +13.19% | ▲ +12.18% | $18.96 (+8.72%) |
Jun 12, 2026 16w ago | Institutional Cluster | $14.81 $15.88 | ▲ +7.22% | ▲ +6.55% | $18.96 (+28.02%) |
May 21, 2026 19w ago | 8-K | $13.53 $14.26 | ▼ −5.40% | ▼ −3.74% | $18.96 (−40.13%) |
May 21, 2026 19w ago | Press Release | $13.66 $14.05 | ▼ −2.86% | ▼ −1.01% | $18.96 (−38.80%) |
May 19, 2026 19w ago | 424B5 | $13.02 $13.90 | ▼ −6.76% | ▼ −4.96% | $18.96 (−45.62%) |
May 19, 2026 19w ago | Press Release | $13.02 $14.43 | ▼ −10.83% | ▼ −9.59% | $18.96 (−45.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access